+31(0)6 188 98 791 info@cryosol-world.com

ABOUT CRYOSOL
TWO ACHIEVE MORE

Our Mission

CryoSol-World (CryoSol) is a new innovative high-tech company that aims to become the global leader in vitrification sample preparation technology. We believe innovation in this field is of vital importance to advance cryo-electron microscopy (cryo-EM) results. This is why our focus is on reliable and reproducible solutions for cryo-EM.

”At CryoSol we believe innovation in sample preparation technology is of vital importance to advance cryo-electron microscopy (cryo-EM) results. Structural biologists need reliable and reproducible solutions to unravel the mysteries of proteins, the molecules that make life. Because proteins play a key role in the development of life-changing medicines, vaccines and to cure diseases like COVID-19 and cancer. A lot of research, knowledge-sharing and hard work is needed to get there.”

Ben Bormans MSc

CEO, CryoSol-World

Our vision

We are passionate about science, and we like to push the boundaries of technology. We are driven to help structural biologists with their challenges to vitrify biological samples. That is why we are focused on enabling reliable, reproducible solutions to vitrify their samples for cryo-EM at high throughput. It takes trust and a flexible, open-minded team that thrives on sharing knowledge. We encourage and value the contributions of all customers, partners and co-workers. Because it is only by working together that we can truly help life scientists in their quest to achieve more groundbreaking research that will make a lasting difference in life.

CryoSol-World team

Ben Bormans

Ben Bormans

CEO

Bart Beulen PhD

Bart Beulen PhD

CTO

Prof. Peter Peters PhD

Prof. Peter Peters PhD

CSO

Frank Nijpels

Frank Nijpels

R&D Engineer & Inventor

Giulia Weissenberger

Giulia Weissenberger

Product Manager

René Henderikx

René Henderikx

Product Specialist

Steef Corvers

Steef Corvers

Senior System Engineer

Emile Asselbergs

Emile Asselbergs

COO

Richard Geschiere

Richard Geschiere

CCO

Tom Van Osch

Tom Van Osch

CFO

Erin Leahy

Erin Leahy

Applications Scientist

Jean-Christophe Guillaume

Jean-Christophe Guillaume

Manager Customer Service and Operations

History of CryoSol-World

CryoSol-World is founded on research executed at Maastricht University, dating back to the early 90’s of the previous century.  In close collaboration between Dr. Peter Frederik of the cryo-mlectron microscopy (cryo-EM) laboratory and Maastricht Instruments, a device for automated vitrification of very thin samples, the ‘Vitrobot’, was developed. The Vitrobot rapidly proved to be a fitting solution for vitrification and became the standard for sample preparation for cryo-EM after licensing it to FEI in 2002 (now ThermoFisher Scientific).

Today, the Division of Nanoscopy of the Maastricht MultiModal Molecular Imaging Institute (M4I) continues advancing structural biology by tackling tuberculosis and cancer. Led by Prof. dr. Peter Peters, both single particle analysis as well as electron tomography are applied to gain understanding of macromolecular nano-machinery inside human cells and their pathogens. The aim is applying this knowledge for the design of effective drugs and treatments for diseases that affect millions of people worldwide.

Since the development of the Vitrobot, the Division of Nanoscopy and engineers from Instrument Development, Engineering and Evaluation (IDEE) of Maastricht University have been developing the next generation technology and applications in cryo-workflows to study single particles, cells and organoids. This has resulted in the VitroJet. CryoSol was founded in March 2018 by scientists and enterpreneurs with a track record in the field of cryo-EM and originates from research performed at Maastricht University, the Netherlands. Our VitroJet technology has been invented by the team responsible for the development of its predecessor, the Vitrobot, the former standard in cryo-sample preparation equipment.

M4I Research team, Maastricht University, the Netherlands

CryoSol cooperates with the M4I Division of Nanoscopy department of Maastricht University, headed by Prof. dr. Peter Peters. M4I Division of Nanoscopy strives for greater insight into the 3D structure of proteins in cells, paving the way for developing more effective treatments for diseases such as cancer and tuberculosis while gaining better understanding of how protein complexes manage healthy and diseased cells, allowing drugs, vaccines and treatments to work more effectively.